Suchergebnisse - "Zeng, Shiyan"

PubPharm (13)

1

Novel Prognostic Implications of PAQR3 Expression in Breast Cancer after Curative Resection and Systemic Therapy

enthalten in: ResearchSquare.com | 2021

von Zeng, S. | Lei, S. | Xiao, Y. | +2

2

MAPK Pathway Inhibition as A Rational Therapeutic Strategy for MiR-138-5p/PAQR3 Dysregulation-mediated Epirubicin Resistance in Triple-negative Breast Cancer

enthalten in: bioRxiv.org | 2021

von Huang, J. | Zeng, S. | Xiao, Y. | +5

3

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

enthalten in: Breast cancer research and treatment | 2021

von Liu, S. | Zeng, S. | Xia, L. | +7

4

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

enthalten in: Breast cancer research and treatment | 2020

von Liu, S. | Zeng, S. | Xia, L. | +7

5

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

enthalten in: Breast cancer research and treatment | 2020

von Liu, S. | Zeng, S. | Xia, L. | +7

6

Tumor-infiltrating lymphocytes benefit prediction of axillary pathologic response and prognostication of event-free survival in HER2-positive and biopsy-proven node-positive breast cancer treated with neoadjuvant therapy

enthalten in: Breast cancer research and treatment | 2020

von Liu, S. | Zeng, S. | Xia, L. | +7

7

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer

enthalten in: Cancer cell international | 2020

von Zhang, P. | Long, Q. | Zeng, S. | +2

8

FOXC1-induced LINC01123 acts as a mediator in triple negative breast cancer

enthalten in: Cancer cell international | 2020

von Zhang, P. | Long, Q. | Zeng, S. | +2

9

Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes

enthalten in: Cancer management and research | 2020

von Liu, S. | Mou, E. | Zeng, S. | +8

10

MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation

enthalten in: OncoTargets and therapy | 2020

von Luo, J. | Zeng, S. | Tian, C.